Michael Pfeffer
Payments from drug & device makers
$24,479,738in general payments, 2019–2025
Across 1,585 payments — averaging $15,445 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$5.1M
- Eisai Inc.$4.3M
- AbbVie$2.8M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.3M
- Genentech, Inc.$1.9M
- Eli Lilly$1.6M
- plus $6.4M from 14 others
$167,835in research payments, 2019–2025
Across 43 payments — averaging $3903.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$162K
- Eli Lilly$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$760
General payments by program year
19
22
23
24
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 127 | $5,128,223 |
| Eisai Inc. | 352 | $4,308,753 |
| AbbVie | 103 | $2,833,543 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 602 | $2,297,620 |
| Genentech, Inc. | 42 | $1,852,838 |
| Eli Lilly | 19 | $1,616,920 |
| Teva Pharmaceuticals USA, Inc. | 191 | $1,417,074 |
| E.r. Squibb & Sons, L.L.C. | 24 | $1,312,772 |
| UCB SA | 10 | $1,261,363 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 22 | $1,065,466 |
| Sage Therapeutics, LLC | 14 | $400,115 |
| Regeneron | 29 | $394,329 |
| Grifols Biologicals LLC | 3 | $317,858 |
| Avanir Pharmaceuticals, Inc. | 19 | $130,981 |
| Integrative Research Laboratories Sweden AB | 7 | $71,330 |
| H. Lundbeck A S | 12 | $47,477 |
| Astrazeneca UK Limited | 2 | $15,250 |
| Chiesi USA, Inc. | 3 | $6,952 |
| Idorsia Pharmaceuticals US Inc | 3 | $787 |
| Gilead | 1 | $85 |
How this compares
$24,479,738 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Miami
- Silvia DelgadoMiami$11M
- Angel CarrascoMiami$10.3M
- Michael BenatarMiami$5.4M
- Kottil RammohanMiami$5M
- Macarena de la FuenteMiami$4.9M
- Victor FaradjiMiami$4M
- Brad HerskowitzMiami$3.1M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.